These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20737641)

  • 1. On the possibility of self-induction of drug protein binding.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Oct; 99(10):4400-5. PubMed ID: 20737641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration-dependent plasma protein binding: Expect the unexpected.
    Nation RL; Theuretzbacher U; Tsuji BT;
    Eur J Pharm Sci; 2018 Sep; 122():341-346. PubMed ID: 30026170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the influence of protein binding on pharmacological activity of drugs.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Apr; 99(4):2153-65. PubMed ID: 19827100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consideration of the linear concentration increase of the unbound drug fraction in plasma.
    Berezhkovskiy LM
    J Pharm Sci; 2009 Feb; 98(2):383-93. PubMed ID: 18704923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the calculation of the concentration dependence of drug binding to plasma proteins with multiple binding sites of different affinities: determination of the possible variation of the unbound drug fraction and calculation of the number of binding sites of the protein.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Feb; 96(2):249-57. PubMed ID: 17051587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of unbound volumes of drug distribution in pharmacokinetic calculations.
    Stepensky D
    Eur J Pharm Sci; 2011 Jan; 42(1-2):91-8. PubMed ID: 21050885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement and analysis of unbound drug concentrations.
    Wright JD; Boudinot FD; Ujhelyi MR
    Clin Pharmacokinet; 1996 Jun; 30(6):445-62. PubMed ID: 8792057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
    Longhi R; Corbioli S; Fontana S; Vinco F; Braggio S; Helmdach L; Schiller J; Boriss H
    Drug Metab Dispos; 2011 Feb; 39(2):312-21. PubMed ID: 21071520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances.
    Wagner JG
    Eur J Clin Pharmacol; 1976; 10(6):425-32. PubMed ID: 1001358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bioanalytical challenge of determining unbound concentration and protein binding for drugs.
    Nilsson LB
    Bioanalysis; 2013 Dec; 5(24):3033-50. PubMed ID: 24320129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic elimination of drugs with concentration-dependent serum protein binding.
    Huang JD; Oie S
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):67-81. PubMed ID: 6747819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of site-specific binding to plasma albumin in drug availability to brain.
    Mandula H; Parepally JM; Feng R; Smith QR
    J Pharmacol Exp Ther; 2006 May; 317(2):667-75. PubMed ID: 16410405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Capacity limited pharmacokinetics, a mechanism of drug toxicity (author's transl)].
    Dettli L
    Arzneimittelforschung; 1977; 27(96):1844-8. PubMed ID: 579151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure--plasma protein binding relationships of acidic drugs.
    Zhivkova Z; Doytchinova I
    J Pharm Sci; 2012 Dec; 101(12):4627-41. PubMed ID: 22961754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding.
    Liu X; Smith BJ; Chen C; Callegari E; Becker SL; Chen X; Cianfrogna J; Doran AC; Doran SD; Gibbs JP; Hosea N; Liu J; Nelson FR; Szewc MA; Van Deusen J
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1254-62. PubMed ID: 15743928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.